Revenue YoY
+1.78%
Operating Income YoY
+13.93%
Net Income YoY
+34.20%
Net Margin Δ
+362 bps
Net income bridge for Bristol-Myers Squibb (BMY) — TTM through Q1 2026 vs TTM through Q1 2025
Δ Net income: $1.86B+34.20%
Profit bridge breakdown for Bristol-Myers Squibb (BMY) — TTM through Q1 2026 vs TTM through Q1 2025
| Driver | Contribution | % of Δ |
|---|---|---|
| Prior Net Income | $5.42B | — |
| Revenue | $846M | +45.6% |
| Cost of Revenue | $4.3B | +231.8% |
| Operating Expenses | -$3.63B | -195.4% |
| Other Income / Expense | $1.97B | +106.0% |
| Income Tax | -$1.65B | -89.1% |
| Other Items | $20M | +1.1% |
| Net Income | $7.28B | — |
- Prior Net Income$5.42B
- Revenue$846M
- Cost of Revenue$4.3B
- Operating Expenses-$3.63B
- Other Income / Expense$1.97B
- Income Tax-$1.65B
- Other Items$20M
- Net Income$7.28B
Identity check: drivers reconcile to ΔNI within $0.00 ✓
Want the full P&L structure?Income Statement Waterfall
Frequently asked questions
Data & methodology
Bristol-Myers Squibb (BMY) Key Financials
Charts, filings, and peer comparison for every metric
Income Statement
Balance Sheet
Cash Flow
Forecast & Valuation
Operations
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
Overview
Income Statement
Capital Return
- Buybacks0.08% TTM
- Dividend Profile4.13% yield
- Dividend Calculator
- Dividend Forecast
- Dividend Capture
- Stock Split History6 splits
How this company returns cash to shareholders — buybacks, dividends, and stock splits.